InvestSMART

Careteq Limited (ASX:CTQ)

ALERT: Price-sensitive ASX Announcement for CTQ
Current share price for CTQ : $0.011 0.001 (10%)+
Announcement
Release
29 Aug 2025 9:26AM
Price at Release
$0.010
Full Release
download
Summary
Careteq Limited reported its FY25 preliminary full year results, highlighting a 5.4% increase in revenue to $7.6 million and a significant improvement in Group EBITDA from continuing operations, which rose by 171% to $0.5 million. The company strategically focused on its core areas of medication management and clinical governance, resulting in a return to profitability and a positive EBITDA from continuing operations. Key actions included divesting the unprofitable Sofihub business and acquiring full ownership of the profitable Embedded Health Solutions (EHS) business. The integration of EHS and other platforms is expected to yield further synergies, enhancing operational efficiency and scalability across aged care, home care, and disability sectors. The company anticipates continued revenue growth and profitability in FY26. Additionally, Careteq is addressing an ATO dispute related to historical R&D Tax Incentive claims.
Key Points
  • Revenue increased by 5.4% to $7.6 million
  • Group EBITDA from continuing operations improved by 171% to $0.5 million
  • Focused on medication management and clinical governance
  • Divested Sofihub and acquired full ownership of EHS
  • EHS showed a 13% increase in underlying EBITDA to $1.7 million
  • Integration of platforms expected to yield further synergies
  • Revenue growth and profitability anticipated for FY26
  • Addressing an ATO dispute over R&D Tax Incentive claims
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.